Poorolajal Jalal, et al.
PloS one, 2017
Abstract
Importance
Increased dietary potassium intake is thought to be associated with low blood pressure (BP). Whether potassium supplementation may be used as an antihypertensive agent is a question that should be answered.
Objective
To assess the effect of oral potassium supplementation on blood pressure in patients with primary hypertension.
Search Methods
We searched Medline, Web of Science, Scopus, Cochrane Central Register of Controlled Trials until October 2016. We also screened reference lists of articles and previous reviews. We applied no language restrictions.
Selection Criteria
We included randomized placebo-controlled clinical trials addressing the effect of potassium supplementation on primary hypertension for a minimum of 4 weeks.
Data Collection And Analysis
We extracted data on systolic and diastolic BP (SBP and DBP) at the final follow-up. We explored the heterogeneity across studies using Cochran's test and I2 statistic and assessed the probability of publication bias using Begg's and Egger's tests. We reported the mean difference (MD) of SBP and DBP in a random-effects model.
Results
We found a total of 9059 articles and included 23 trials with 1213 participants. Compared to placebo, potassium supplementation resulted in modest but significant reductions in both SBP (MD -4.25 mmHg; 95% CI: -5.96 to -2.53; I2 = 41%) and DBP (MD -2.53 mmHg; 95% CI: -4.05 to -1.02; I2 = 65%). According to the change-score analysis, based on 8 out of 23 trials, compared to baseline, the mean changes in SBP (MD -8.89 mmHg; 95% CI: -13.67 to -4.11) and DBP (MD -6.42 mmHg; 95% CI: -10.99 to -1.84) was significantly higher in the intervention group than the control group.
Conclusions
Our findings indicated that potassium supplementation is a safe medication with no important adverse effects that has a modest but significant impact BP and may be recommended as an adjuvant antihypertensive agent for patients with essential hypertension.
| PMID: | 28419159 |
|---|---|
| Category: | General properties of Potassium |
Articles similar to "Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials."
- The properties of Potassium: Potassium intake, bioavailability, hypertension, and glucose control. (Potassium is an essential nutrient...)
- The properties of Potassium: Clinical perspectives on the rationale for potassium supplementation. (Hypokalemia is a common electrolyte disturbance, observed in > 20% of hospitalized patients...)
- The properties of Potassium: The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. ( Several intervention studies have investigated the relation between potassium intake and blood-pressure, particularly in hypertensive subjects... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )
- The properties of Potassium: Potassium chloride supplementation diminishes platelet reactivity in humans. (The prevalence of occlusive stroke is inversely correlated with potassium intake... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )
- The properties of Potassium: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. (Randomized trials have shown that increasing potassium intake lowers blood pressure... Potassium supplementation in hypertensives was generally associated with decreased blood pressure, particularly in high sodium consumers, subjects not on hypertensive drug treatment, and those in the lowest category of potassium intake. An adequate dietary intake of potassium, in the order of 90mmol/day, should be achieved for blood pressure control. )
Previous article
Potassium intake, bioavailability, hypertension, and glucose control.
Next article
Clinical perspectives on the rationale for potassium supplementation.